共 13 条
[1]
Antioxidant action of the antiarrhythmic drug mexiletine in brain membranes. Demirpence E,Caner H,Bavbek M,et al. Japanese Journal of Pharmacology . 1999
[2]
Experimental approaches to white matter disease. Pantoni L. Dementia and Geriatric Cognitive Disorders . 1998
[3]
Cerebral white matter is highly Vulnerable to ischemia. Pantoni L,Garcia JH,Gutierrez JA. Stroke . 1996
[4]
Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals. Irving EA,Yatsushiro K,Mc Culloch J,et al. Journal of Cerebral Blood Flow and Metabolism . 1997
[5]
Drug development for stroke:importance of protecting cerebral white matter. Dewar D,Yam P,McCulloch J. European Journal of Pharmacology . 1999
[6]
The effect of insulin-like growth factors on brain myelination and their potential therapeutic application in myelination disorders. Zumkeller W. Europ J Paediatr Neurol . 1997
[7]
Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptormediated excitotoxicity. McDonald JW,Althomsons SP,Hyrc KL,et al. Nature Medicine . 1998
[8]
VIP neuroprotection against excitotoxic lesions of the developing mouse brain. Gressens P. Annals of the New York Academy of Sciences . 1999
[9]
Anoxic injury in the rat spinal cord: pharmacological evidence for multiple steps in Ca2+dependent injury of the dorsal columns. Imaizumi T,Kocsis JD,Waxman SG. Journal of Neurotrauma . 1997
[10]
Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Wakita H,Tomimoto H,Akiguchi I,et al. Brain Research . 1998